225 related articles for article (PubMed ID: 25142005)
1. Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly.
Seither KM; McMahon HA; Singh N; Wang H; Cushman-Nick M; Montalvo GL; DeGrado WF; Shorter J
Biochem J; 2014 Nov; 464(1):85-98. PubMed ID: 25142005
[TBL] [Abstract][Full Text] [Related]
2. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
3. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
4. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
5. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
[TBL] [Abstract][Full Text] [Related]
6. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
[TBL] [Abstract][Full Text] [Related]
7. C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42.
Chemuru S; Kodali R; Wetzel R
J Mol Biol; 2016 Jan; 428(2 Pt A):274-291. PubMed ID: 26122432
[TBL] [Abstract][Full Text] [Related]
8. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Sato M; Murakami K; Uno M; Nakagawa Y; Katayama S; Akagi K; Masuda Y; Takegoshi K; Irie K
J Biol Chem; 2013 Aug; 288(32):23212-24. PubMed ID: 23792961
[TBL] [Abstract][Full Text] [Related]
9. Aβ(39-42) modulates Aβ oligomerization but not fibril formation.
Gessel MM; Wu C; Li H; Bitan G; Shea JE; Bowers MT
Biochemistry; 2012 Jan; 51(1):108-17. PubMed ID: 22129303
[TBL] [Abstract][Full Text] [Related]
10. Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers.
Ahn JH; Hu Y; Hernandez M; Kim JR
Biochem Biophys Res Commun; 2011 Oct; 414(1):79-83. PubMed ID: 21945434
[TBL] [Abstract][Full Text] [Related]
11. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
12. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.
Ruiz-Riquelme A; Mao A; Barghash MM; Lau HHC; Stuart E; Kovacs GG; Nilsson KPR; Fraser PE; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2021 May; 9(1):83. PubMed ID: 33971978
[TBL] [Abstract][Full Text] [Related]
13. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
14. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
Jäkel L; Boche D; Nicoll JAR; Verbeek MM
Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
[TBL] [Abstract][Full Text] [Related]
15. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.
Cam M; Durieu E; Bodin M; Manousopoulou A; Koslowski S; Vasylieva N; Barnych B; Hammock BD; Bohl B; Koch P; Omori C; Yamamoto K; Hata S; Suzuki T; Karg F; Gizzi P; Erakovic Haber V; Bencetic Mihaljevic V; Tavcar B; Portelius E; Pannee J; Blennow K; Zetterberg H; Garbis SD; Auvray P; Gerber H; Fraering J; Fraering PC; Meijer L
J Alzheimers Dis; 2018; 62(4):1663-1681. PubMed ID: 29504531
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures.
Fu L; Sun Y; Guo Y; Chen Y; Yu B; Zhang H; Wu J; Yu X; Kong W; Wu H
J Pept Sci; 2017 Mar; 23(3):245-251. PubMed ID: 28211253
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide.
Westlind-Danielsson A; Arnerup G
Biochemistry; 2001 Dec; 40(49):14736-43. PubMed ID: 11732892
[TBL] [Abstract][Full Text] [Related]
18. An azobenzene photoswitch sheds light on turn nucleation in amyloid-β self-assembly.
Doran TM; Anderson EA; Latchney SE; Opanashuk LA; Nilsson BL
ACS Chem Neurosci; 2012 Mar; 3(3):211-20. PubMed ID: 22860190
[TBL] [Abstract][Full Text] [Related]
19. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
[TBL] [Abstract][Full Text] [Related]
20. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
